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Abstract 
Background: The burden of malaria in terms of morbidity and mortality is huge is Sub‑Saharan Africa, particularly 
among pregnant women. Among the measures to curb down this burden include intermittent preventive treat‑
ment (IPT) and effective case management. These strategies were adopted by Ghana and implemented since 2003; 
however, there is still high dropout rate in IPT coverage. This study sought to investigate factors contributing to high 
dropout rate between IPT1 and IPT3 in the Tamale Metropolis, one of the health facilities with the highest IPT dropout 
rates in Ghana.
Methods: Survey, in‑depth interviews and short ethnographic techniques were conducted among pregnant 
women, antenatal care (ANC) health workers and heads of health facilities to investigate factors which account for 
dropout rate of intermittent treatment of malaria.
Results: Shortage of sulphadoxine pyrimethamine (SP), inadequate supply of portable water for administration of SP, 
unavailability of IPT during outreach services, lack of knowledge by ANC staff about the dropout rate in their area of 
jurisdiction and poor attitude of some health workers were identified as barriers to achieving high IPT3 coverage.
Conclusions: Late ANC visit, provider and logistical barriers account for the women’s missed opportunities to 
prevent malaria in pregnancy through IPT. Addressing the above barriers will contribute to saving lives and ensuring 
progress towards the goal of combating malaria as well as reducing maternal, neonatal and child mortalities.
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Background
The toll of malaria is estimated at 300 million cases each 
year worldwide of which more than 90 % occur in Sub-
Saharan Africa [1]. Approximately fifty million women 
living in malaria endemic countries throughout the world 
become pregnant, of whom over half live in tropical areas 
of Africa with intense transmission of plasmodium falci-
parum [2]. An estimated ten thousand of these women 
and two hundred thousand of their infants die as a result 
of malaria infection during pregnancy [2].
Malaria is a complex public health problem in Afri-
can, where most cases and deaths due to the disease 
occur. An estimated 74 % of the population in the African 
region live in areas that are highly endemic for malaria 
[3]. Maternal malaria is associated with serious adverse 
pregnancy outcomes such as maternal deaths, maternal 
anaemia and low birth weight in most malaria endemic 
countries. Among pregnant women, malaria accounts 
for 13.8 % of out patient department attendance, 10.6 % 
of admissions and 9.4 % of deaths [4]. The African Sum-
mit on Roll Back Malaria in April 2000 adopted the 
Abuja Declaration in which regional leaders committed 
themselves to ensuring that 60 % of pregnant women in 
malaria-endemic communities accessed effective preven-
tion and treatment of malaria by 2005 [5].
One major recommended means of preventing malaria 
during pregnancy is intermittent preventive treat-
ment (IPT) with sulphadoxine pyrimethamine (SP) as a 
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prophylactic treatment strategy to help reduce the severe 
burden and disastrous effects of malaria on pregnant 
women and their unborn babies [1]. The World Health 
Organisation (WHO) recommended that the policy for 
the prevention of malaria during pregnancy in areas 
of stable transmission should emphasize a preventive 
package of intermittent preventive treatment (IPT) and 
Insecticide Treated bed Nets and ensure effective case 
management of malaria illness [6].
The IPT package ensures that all pregnant women in 
areas of stable malaria transmission receive at least two 
doses of IPT after quickening, that is, after 16 weeks of 
gestation. Secondly, a schedule of four ANC visits should 
be available for a pregnant woman with three occurring 
after quickening with the delivery of IPT at each sched-
uled visit to ensure that a high proportion of women 
received at least two doses of IPT.
Intermittent Preventive Treatment of malaria in 
pregnancy using SP approach has been shown to be 
safe, inexpensive and effective. A study by Verhoeff 
et al. [7] in Malawi evaluating IPT showed a decline in 
placental malaria infection (32–23 %) and in the num-
ber of low birth weight babies (23–10  %). In Ghana, 
the recommended doses for IPT is three doses of SP as 
directly observed treatment (DOT) following screen-
ing for allergy and other reactions to sulfa drugs [1]. 
IPT with SP is provided as part of a comprehensive 
antenatal package to control maternal anaemia. Inter-
mittent preventive treatment with SP for malaria in 
pregnancy in areas of high or seasonal malaria trans-
mission has been shown to increase both maternal 
haemoglobin levels and the infant’s birth weight [8–
11]. Similarly, Katsurangawa et al. [12] found that IPT 
reduced relapses and recurrence of malaria in children 
in Brazil.
Ghana adopted IPT with SP as a policy in 2003 in 20 
selected districts but in 2005, it was scaled up nationwide 
to all districts to help reduce the severe burden and dam-
aging effects of malaria morbidity and mortality on the 
pregnant woman and the unborn baby [1, 5].
The drug of choice for IPT in Ghana is SP because of its 
safety, effectiveness in reproductive-age women, and the 
feasibility for use in programmes as it can be delivered as 
a single-dose treatment under direct observation (DOT) 
by the health worker [1]. In addition to the above, SP is 
inexpensive, and has demonstrated high levels of accept-
ance by pregnant women [4]. Its administration twice in 
pregnancy has been found to reduce maternal anaemia 
by 39  % [13], placental malaria by 56  %, and low birth 
weight by 43 % [14].
Statistics available at the Tamale Metropolitan Health 
Directorate in Ghana prior to this study indicates that 
there is a high dropout rate in IPT coverage, especially 
between IPT1 and IPT3  in the Metropolis. The drop-
out rates between IPT1 and IPT3 recorded by year 
were: 2006–56.2 %, 2007–46.9 %, 2008–46 % and 2009–
43.7  % while between IPT1 and IPT2 the following 
were recorded; 2006–33.3 %, 2007–25.5 %, 2008–23.3 % 
and 2009–37.8 [15]. Although there has been a general 
improvement of IPT coverage over the years, the drop-
outs remained generally high, especially between IPT1 
and IPT3.
Due to the numerous advantages associated with the 
use of IPT during pregnancy, one would have thought 
that all pregnant women would adhere to its use. How-
ever, there is a high dropout rate in Ghana because of 
delay in commencement of SP which consequently 
reduces the number of doses a woman receives IPT dur-
ing pregnancy. The age of pregnancy at first ante natal 
clinic (ANC) attendance is thus very crucial if a preg-
nant woman is to obtain all the recommended three 
doses of SP. van Eijk et  al. [10] observed that late first 
ANC attendance and the level of formal education of 
pregnant women contribute to incomplete IPT. Anders 
et  al. [16] have argued that some of the causes of the 
late attendance include women who encounter no prob-
lems during pregnancy and therefore see no need to 
visit the clinic. Other factors reported in previous stud-
ies include travel distance from home to the clinic and 
inability to leave farm work to travel to the clinics  [16, 
17]. Mubyazi et  al. [17], argue that a number of preg-
nant women attend ANC before 16  weeks gestation 
when they are not due to be given SP at that first visit, 
but do not return for their first dose SP at the recom-
mended time. For example, in a study by Anders et  al. 
[16], almost half (48 %) of all respondents had attended 
ANC at or before 4 months of gestation, however 86 % 
of these early attendees did not receive IPT on their first 
visit.
Some studies have found that the uptake of preventive 
treatment of malaria in pregnancy using SP increases 
with higher levels of formal education [18–20]. On the 
contrary, a study done in Tanzania by Marchant et  al. 
[21] showed no evidence of an association between any 
individual factors and second dose coverage beyond liv-
ing in an urban area. Age, marital status, educational 
level of the woman and household socioeconomic status 
were all not associated with second dose coverage of SP. 
However, Acquah [22] illustrated that there is an asso-
ciation between IPT uptake and marital status, employ-
ment, maternal educational level, use of ANC services, 
gestational age at first ANC visit and maternal knowledge 
about malaria was statistically significant. The goal of 
this study was to identify factors which contribute to the 
high dropout rate between IPT1 and IPT3 in the Tamale 
Metropolis in Ghana.
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Methods
Study design
Survey, in-depth interviews and short ethnographic tech-
nique were the main methods employed in this study.
Study area
The study was conducted among 294 respondents in the 
Tamale Metropolis in 2011 over a period of 6 weeks.
Study population
The sampled population included pregnant women 
whose gestation exceeded 36  weeks at antenatal clinics 
(ANC), postnatal mothers whose children were less than 
12 weeks old at Child Welfare Clinic (CWC) and health 
workers comprising heads of health facilities, midwives, 
general nurses, medical assistants and community health 
nurses. The inclusion of only pregnant women whose 
gestation exceeded 36 weeks was necessary in this study 
because they were all expected to have completed the 3rd 
dose of IPT and SP. One hundred and four (104) general 
nurses, mid-wives, nursing assistants, medical assistants, 
community health nurses and public health nurses and 
six heads of facilities were also included in the study as 
they were the health staff that administered the SP and 
would therefore be able to identify the administrative 
bottlenecks that may cause the dropout between IPT1 
and IPT3.
Sampling and sample size
Respondents were drawn from all the six Sub Districts 
in the Tamale Metropolis in proportion to their popula-
tion sizes. Simple random sampling was used to select 
184 pregnant women, postpartum mothers and health 
staff. In addition, a total of 104 ANC workers comprising 
of general nurses, mid-wives, nursing assistants, medical 
assistants, community health nurses and public health 
nurses were randomly selected from six health facilities 
in the six districts within the Tamale Metropolis. The six 
heads of the selected health facilities were also purpo-
sively selected and interviewed.
Data collection
Structured questionnaire and observation guide were 
used for the data collection. The first section of the struc-
tured questionnaire had questions on the description of 
the Sub District where the data were collected, includ-
ing the description of the health facility. The second part 
had questions on the socio-demographic background 
of the respondents, the third part focused on the effects 
of malaria on the pregnant woman and the foetus, the 
awareness, knowledge and perception of respondents 
on intermittent preventive treatment of malaria in preg-
nancy, opinion of the respondents on how to motivate 
mothers to visit the ANC regularly to take SP as part of 
the IPT schedule, while the fifth section was on the atti-
tude of the health staff towards the pregnant women. The 
instrument was pre-tested among a sample of the target 
population in one of the health facilities in the region but 
which was not part of the sampled health facilities. Struc-
tured questionnaires were administered to the heads of 
the health facilities, medical assistants, nurses and mid-
wives as well as nursing mothers at the CWCs and preg-
nant women at ANCs. The ANC cards of all pregnant 
women and postpartum mothers were inspected and 
qualified respondents (pregnant women whose gesta-
tion exceeded 36  weeks and mothers who are less than 
12 weeks after delivery) were identified.
Besides, non-participant observation was employed 
at the ANC’s to investigate the practices and availabil-
ity of logistics for the IPT implementation as well as 
the attitude of health workers toward daily adminis-
tration of the IPT. Non participant observation guide 
included, name of facility, sub-district, health education 
programme drawn for the quarter including malaria in 
pregnancy, health education programme drawn for the 
quarter include intermittent preventive treatment of 
malaria in pregnancy, whether there were visible signs 
of posters of IPT posted on the wall, availability of SP 
available at ANC (health workers issuing SP to clients), 
clients swallowing SP before health workers, ANC staff 
recording SP given in ANC book of clients, the avail-
ability of free safe and clean water for DOT at ANC. The 
instrument for the data collection is appended to this 
report as Additional file 1. The data collection was con-
ducted with assistance of 12 students from the Tamale 
School of Hygiene who were fluent in Dagbani (the main 
language spoken in the area). These assistants were 
mainly engaged in the administration of the question-
naire. The rationale of the study was explained to the 
respondents and they assured of confidentiality of their 
responses as well as the option to opt out at stage of 
the questionnaire administration or refuse to response 
to any question(s) which they do not wish to answer. 
Observations were recorded in the investigator’s note-
book. The qualitative data presented in the report were 
mainly from the observations. The institutional review 
board, through the Population and Health Departmen-
tal Board of the Faculty of Social Sciences of the Univer-
sity of Cape Coast, Ghana, gave the ethical clearance for 
the study. Verbal consents were obtained from partici-
pants and for minors their parents, guidance, or other 
surrogate adults gave consent on their behalf.
Data analysis
In-depth interviews and observations were analysed 
using ethnographic technique by identifying categories 
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and concepts from the data as they emerged. Content 
analysis involving systematic scrutiny of field notebooks 
and derivation of understanding was also used to analyse 
the data. The survey part of the data was presented as fre-
quency in relation to the qualitative findings.
Results
The socio-demographic characteristics of respondents 
are presented in Table  1. Women aged 25–29 were the 
largest age group. Nearly all the women were married 
(95.1 %). Those without any formal education and Mos-
lems were the major educational and religious categories, 
respectively. Furthermore, traders and those with two or 
more children were the major occupational and parity 
categories, respectively (Table 1).
We investigated the administration of SP at the health 
facilities and found that some of the pregnant women 
were not given SP at their first visit. Thirty-two percent 
of pregnant women (58/184) indicated that they were 
not given SP during their first ANC visit while 25.5  % 
(46/184) did not take SP during the subsequent visit.
The respondents sampled for the study were interviewed 
on the number of doses of SP taken and their responses 
are represented in Table  2. Eighty-five percent of the 
respondents received at least one dose of SP, 8.7 % of the 
respondents have received one dose of SP, and 35.3 % of 
them received two doses while 38 % received three doses.
It was observed that most health facilities did not have 
clean water supply. Sixty-seven percent of the respond-
ents confirmed that there was no water at the health 
facilities for the practice of DOT. About 5.4  %  of the 
respondents had their own water, 7.6 % of the respond-
ents said they fetched the water from a tap within the 
health facility, 40.7 % of them bought the water and 0.5 % 
had water from other sources.
It was observed that, generally, the attitude of health 
workers was acceptable. Respondents also indicated that 
reception by staff of the health facilities was good and 
the services they rendered were satisfactory. Despite this, 
some women (32/184) indicated that they were shouted 
at the health facility whiles nearly one out of ten said they 
would not ask health workers questions because they 
(health workers) did not behave well towards them (preg-
nant women) Tables 3 and 4. 
We inquired from the women suggestions to improve 
the coverage of IPT2 and IPT3, and 18.5 % of the them 
said the provision of sachet water was needed, 17.9  % 
indicated respect for clients, 27.7  % said further educa-
tion on IPT was needed, 14.1 % said motivation of moth-
ers was needed to take IPT instead of shouting at them 
while 21.7 % gave other reasons.
When ANC staff’s knowledge regarding the use of IPT 
was investigated, we found that 85.5 % of ANC of them 
could give the right definition of IPT, 88.2 % knew of the 
recommended drug for IPT in Ghana, 58.2 % knew when 
to stop administering IPT, 90  % of the ANC staff knew 
the recommended doses for IPT, 93.6 % knew the correct 
interval for administering IPT and 71.8 % knew the side 
effects.
Ninety percent of the ANC staff reported that they 
observed clients swallowing the SP at the facility. How-
ever, about 56  % of the staff sampled indicated they 
had run short of SP at their facilities. Furthermore, half 
(50.9  %) of the health facilities do not provide IPT ser-
vices during outreach. There was poor monitoring as a 
third (33.6 %) of the facilities were not monitored. Aside 










 Married 175 95.1
 Single 5 2.7
 Co‑habitation 4 2.2
Level of education
 No forma education 82 44.5
 Primary 34 18.5
 JHS/JHS/Middle School 20 10.9
 SSS/SHS 37 20.1
 Technical/vocational 2 1.1
 Tertiary 9 4.9
Religion
 Islam 144 78.3
 Christianity 34 18.5
 Traditional 3 1.6
 Others 3 1.6
Occupation
 Government workers 19 10.3
 Farmers 33 17.9
 Traders 61 33.3
 Food processors 25 13.6
 Seamstress 21 11.4
 Hair dressers 17 9.2
 Others 8 4.3
Parity
 Nil 19 12.4
 1–2 77 41.8
 Above 2 88 45.8
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the poor monitoring, on the coverage, only a few (5.5 %) 
of the ANC staff were aware of the expected or accept-
able margin of dropout rate.
An observation guide was used to determine the level 
of health education on malaria in general, malaria in 
pregnancy, intermittent preventive of malaria in preg-
nancy on the health education roster of various health 
facilities as well as whether the health workers who 
administered the SP educated the pregnant women on 
the IPT schedules. The findings show that most of the 
facilities visited had malaria on their quarterly health 
education schedule. However, none of the facilities fac-
tored in malaria in pregnancy and intermittent preven-
tive treatment of malaria in pregnancy in their quarterly 
health education programme.
Discussion
A number of factors have been observed or raised by 
respondents as influencing the administration of IPT at 
the health facilities. These factors can either positively or 
negatively affect the IPT administration process. Some of 
these factors include the poor administration of SP at the 
facility, improper planning of stock management leading 
to the shortage of SP, health workers’ knowledge on IPT, 
health workers’ attitude towards client, unavailability of 
IPT services during outreach activities and health work-
ers themselves giving wrong messages about the timing 
of the administration of the drug could undermine the 
achievement of IPT3 coverage.
A third of respondents stated that they had not taken 
SP during their first visit while a quarter also reported 
they did not take it in the subsequent visit. This might 
be so because some of the respondents visited the ANC 
before 16  weeks and therefore were not due for SP, it 
could also be associated with the shortages of SP as indi-
cated by the ANC staff. If it is due to shortage, pregnant 
women may become reluctant in visiting ANC.
The recommended doses of IPT for pregnant women 
in Ghana are three doses in order to realise the full 
benefits of the IPT. Nevertheless, less than half of preg-
nant women reported receiving IPT three times during 
pregnancy. Our finding of less than three doses of IPT 
by some pregnant women is similar to those found in 
Uganda [23] where it was reported that only 35.8  % of 
women received two or more doses of SP.
Directly observed treatment (DOT) requires that SP 
be administered under the direct observation of a health 
worker. This is a sure way of ensuring that the pregnant 
woman takes the SP. The availability of water is one of the 
major necessary logistics needed to practice DOT for IPT. 
Taking SP requires the availability of water at the facility 
especially to ensure that the client take SP at the facil-
ity under observation as required by the IPT programme 
in Ghana instead of taking it at home. In this study, we 
observed that water was not available at most of the health 
facilities for pregnant women to take the SP. A number of 
the women bought their own water at the health facility 
to take SP. This could discourage some women from visit-
ing ANC especially those who may not have money to buy 
the water even though all other antenatal services were 
offered free of charge. The unavailability of water at most 
of the facilities could also lead to low intake of SP and con-
sequently high dropout rate. In Ghana, a study by Presi-
dent’s Malaria Initiative (PMI) [24] cited health workers as 
contributing to missing the opportunity to get all pregnant 
women who visit hospital to get IPT. Poor health worker 
practices have also been identified among others as opera-
tional challenges in delivering IPT [25].
In the Korogwe district of north-east Tanzania, Mub-
yazi et  al. [17] found that only a quarter of pregnant 
women took SP under observation by a health worker. 
In this study, nine out of every ten ANC health worker 
reported that they observed the women to swallow 
Table 2 Number of SP doses taken




Can’t remember 33 17.9
Total 184 100
Table 3 Attitude of staff
Attitude Frequency Percentage
Good reception by staff 177 96.2
Not asked questions due to bad behaviour 16 8.7
Shouted at 32 17.4
Questions satisfactorily answered 127 69
Satisfactory service 167 90.8
Good behaviour by staff 120 65.2
Table 4 Knowledge of ANC staff on IPT
Component of knowledge Frequency Percentage
Correct def. of IPT 94 85.5
Recommended drug for IPT 97 88.2
When not to give IPT 64 58.2
Recommended doses for IPT 99 90
Correct interval for IPT 103 93.6
Side effects of SP 79 71.8
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the medicine thus higher than what was reported in 
Tanzania.
When clients’ views were sought on what should be 
done to improve the coverage of IPT2 and IPT3, the pro-
vision of sachet water, respect for clients, further edu-
cation on IPT and motivation of mothers to take IPT 
instead of shouting at them were the main suggestions 
which emerged. The views expressed by the respondents 
are essential and should be factored into interventions 
which seek to address the high IPT dropout rates. It was 
observed that, although, the attitude of staff towards the 
pregnant women was generally acceptable, the attitude 
of some needs to be improved in order not to discourage 
the women from patronising ANC services.
The successful implementation of the IPT strat-
egy relies on the level and type of training given to the 
health staff. A study by Brabin et al. [26] in the Gambia 
showed that women relied on health workers to pro-
vide safe drugs at the correct time. Without good train-
ing and close supervision of health care workers, there 
is the risk that pregnant women may not be treated well 
or health workers may shirk their responsibilities. The 
ANC staff knew the recommended doses for IPT, and 
nine out of ten knew the correct interval for administer-
ing IPT as well as the side effects. This is an indication 
that the knowledge of health workers in Tamale Metrop-
olis is high, however, this does not reflect on the knowl-
edge level of the women in describing the actual concept 
of IPT and the use of IPT in preventing malaria. This 
confirms the lack of health education for the pregnant 
women, which was also observed in this study.
About half of the health facilities did not provide IPT 
services during outreach activities in the communities. 
The shortage of SP, suspension of IPT programme during 
shortage and non-provision of IPT services during out-
reach could contribute to the high dropout rate between 
IPT1 and IPT3. According to ANC staff, IPT services 
virtually came to a halt anytime there was a shortage. A 
study by Tarimo [27] reported that 40 % of women inter-
viewed in Tanzania had not received SP because of SP 
unavailability, suggesting that stock shortage is a major 
barrier to malaria prevention in the region.
Monitoring and supervision ensures that logistics and 
human resources needed for the implementation of the 
IPT programme at the facility level are made available 
at the appropriate times and used judiciously for their 
intended purposes. It also provides the opportunity for 
identifying deficiencies and urgently addressing them 
to ensure a continuity of the programme and achieve-
ment of its objectives. We found that monitoring of 
the IPT was poor, implying that most of the ANC staff 
were unable to track their IPT coverage and hence will 
be less likely to identify the high dropout rates early and 
intervene. It is possible that the inadequate monitoring of 
the IPT activities has also contributed to the high drop-
out rate in the Tamale Metropolis.
Conclusion
Late ANC visit, shortage of SP, provider attitude and 
poor knowledge of pregnant women on IPT for malaria 
treatment might have contributed to the high IPT drop-
out  rates. Logistics for IPT are necessary for its con-
tinuity. There should be a planned schedule for the 
procurement of SP to avoid shortages that usually lead to 
the suspension of the whole IPT programme in some of 
the health facilities. Efforts should also be made to pro-
vide portable water at ANC to be used by the clients to 
take SP under DOT, since DOT is necessary in order to 
measure the coverage of  the IPT. As IPT is a free service, 
the government of Ghana and other benevolent organi-
sations should give financial assistance to health service 
providers to ensure the availability of SP and continuity 
of the IPT services. Such aid will for example help pro-
viders procure the necessary logistics to avoid the short-
ages of SP. It will also help in the provision of portable 
water to ensure the practice of DOT.
Special education should be given to ANC staff on 
the key monitoring indicators such as measurement 
of coverage and dropout rates. A system should be 
developed to aid IPT providers to track and monitor 
IPT coverage in their areas of operation, preferably 
monthly. This will help ANC staff to monitor their 
performance, identify problems and take immediate 
actions to address them.
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